Arlington Partners LLC Edwards Lifesciences Corp Transaction History

Arlington Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$61.71 - $77.76 $74,545 - $93,934	1,208 Added 509.7%	1,445 $110,000
Q3 2023 Oct 24, 2023	SELL	$69.28 - $93.38 $25,079 - $33,803	-362 Reduced 60.43%	237 $16,000
Q2 2023 Jul 26, 2023	BUY	$81.41 - $94.33 $29,470 - $34,147	362 Added 152.74%	599 $56,000
Q1 2023 Apr 26, 2023	BUY	$74.26 - $84.51 $1,782 - $2,028	24 Added 11.27%	237 $19,000
Q1 2022 Apr 14, 2022	SELL	$101.96 - $128.34 $5,199 - $6,545	-51 Reduced 19.32%	213 $25,000
Q4 2021 Jan 18, 2022	BUY	$106.37 - $130.68 $28,081 - $34,499	264 New	264 $34,000
Q2 2020 Jul 13, 2020	SELL	$57.54 - $76.95 $115 - $153	-2 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$52.41 - $81.0 $104 - $162	2 New	2 $0

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.